Pathogenesis of retinopathy of prematurity: A literature review
DOI:
https://doi.org/10.3889/aph.2025.6160Keywords:
retina, retinopathy of prematurity, hypoxia, pathogenesis, neovascularizationAbstract
Retinopathy of prematurity is a vasoproliferative disease of the retina that affects premature infants, especially those with low birth weight and high oxygen exposure. It is still the leading cause of blindness in children worldwide. The pathophysiological mechanism occurs in two phases: the first known as hyperoxia-induced vascular regression and the second - hypoxia-induced pathological neovascularization. An imbalance of a large number of molecules and cytokines is involved in the development of this disease. The main ones are: vascular endothelial growth factor (VEGF); insulin-like growth factor-1 (IGF-1); Hypoxia-inducible factor-1 alfa (HIF-1α); as well as a large number of proinflammatory mediators. Various factors such as: oxygen fluctuation, nutritional factors, genetic and epigenetic factors have a certain impact on the development and progression of Retinopathy of prematurity. The motive of this literature review is to present the current views and knowledge regarding the pathophysiological mechanisms as well as potential biomarkers for timely recognition of premature infants at high risk for ROP. For this purpose, we approached a data search from two large databases of biomedical literature: Medline and Embase by entering the keywords: retina, retinopathy of prematurity, hypoxia, pathogenesis, neovascularization. From the obtained data, we selected those papers that present the latest knowledge in this field of ophthalmology.
Downloads
References
Blencowe H, Lawn JE, Vazquez T, Fielder A, Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res. 2013;74(Suppl 1):35-49. doi: 10.1038/pr.2013.205. PMID: 24366462; PMCID: PMC3873709.
Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A; International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518-25. doi: 10.1542/peds.2004-1180. Epub 2005 Apr 1. PMID: 15805336.
Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E, Dodik I, Duvnjak S. Risk factors for retinopathy of prematurity in premature born children. Med Arch. 2015;69(6):409-13. doi: 10.5455/medarh.2015.69.409-413. PMID: 26843736; PMCID: PMC4720470.
Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38(7):397-432. doi: 10.1136/bjo.38.7.397. PMID: 13172417; PMCID: PMC1324374.
Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):618-637. doi: 10.1016/j.survophthal.2018.04.002. Epub 2018 Apr 19. PMID: 29679617; PMCID: PMC6089661.
Terry TL. Extreme prematurity and fibroblastic overgrowth of persistent vascular sheath behind each crystalline lens: I. Preliminary report. Am J Ophthalmol. 2018;192:xxviii. doi: 10.1016/j.ajo.2018.05.024. PMID: 30055814.
Hong EH, Shin YU, Cho H. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clin Exp Pediatr. 2022;65(3):115-126. doi: 10.3345/cep.2021.00773. Epub 2021 Oct 12. PMID: 34645255; PMCID: PMC8898617.
Strube YNJ, Wright KW. Pathophysiology of retinopathy of prematurity. Saudi J Ophthalmol. 2022;36(3):239-242. doi: 10.4103/sjopt.sjopt_18_22. PMID: 36276256; PMCID: PMC9583358.
Hård AL, Smith LE, Hellström A. Nutrition, insulin-like growth factor-1 and retinopathy of prematurity. Semin Fetal Neonatal Med. 2013;18(3):136-142. doi: 10.1016/j.siny.2013.01.006. Epub 2013 Feb 18. PMID: 23428885; PMCID: PMC3809333.
Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci. 1995;15(7 Pt 1):4738-47. doi: 10.1523/JNEUROSCI.15-07-04738.1995. PMID: 7623107; PMCID: PMC6577882.
Chu Y, Hughes S, Chan-Ling T. Differentiation and migration of astrocyte precursor cells and astrocytes in human fetal retina: relevance to optic nerve coloboma. FASEB J. 2001;15(11):2013-5. doi: 10.1096/fj.00-0868fje. Epub 2001 Jul 9. PMID: 11511521.
Smith LE. Pathogenesis of retinopathy of prematurity. Semin Neonatol. 2003;8(6):469-73. doi: 10.1016/S1084-2756(03)00119-2. PMID: 15001119.
Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007;10(2):133-40. doi: 10.1007/s10456-007-9066-0. Epub 2007 Feb 27. PMID: 17332988.
Hartnett ME. Pathophysiology of Retinopathy of Prematurity. Annu Rev Vis Sci. 2023;9:39-70. doi: 10.1146/annurev-vision-093022-021420. Epub 2023 May 10. PMID: 37164029.
Sehgal P, Narang S, Chawla D, Gupta S, Jain S, Sharma U, Katoch D, Kaur J. Systemic biomarkers of retinopathy of prematurity in preterm babies. Int Ophthalmol. 2023;43(5):1751-1759. doi: 10.1007/s10792-022-02576-z. Epub 2022 Nov 29. PMID: 36443542; PMCID: PMC9707116.
Quinn GE. The 'ideal' management of retinopathy of prematurity. Eye (Lond). 2005;19(10):1044-9. doi: 10.1038/sj.eye.6701960. PMID: 16304583.
Modrzejewska M, Zdanowska O, Połubiński P. The Role of HIF-1α in Retinopathy of Prematurity: A Review of Current Literature. J Clin Med. 2024;13(14):4034. doi: 10.3390/jcm13144034. PMID: 39064074; PMCID: PMC11277540.
Cakir B, Hellström W, Tomita Y, Fu Z, Liegl R, Winberg A, et al. IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants. JCI Insight. 2020;5(19):e140363. doi: 10.1172/jci.insight.140363. PMID: 33004691; PMCID: PMC7566718.
Stone WL, Shah D, Hollinger SM. Retinopathy of prematurity: an oxidative stress neonatal disease. Front Biosci (Landmark Ed). 2016;21(1):165-77. doi: 10.2741/4382. PMID: 26709767.
Graziosi A, Perrotta M, Russo D, Gasparroni G, D'Egidio C, Marinelli B, et al. Oxidative stress markers and the retinopathy of prematurity. J Clin Med. 2020;9(9):2711. doi: 10.3390/jcm9092711. PMID: 32825796; PMCID: PMC7563779.
Rivera JC, Dabouz R, Noueihed B, Omri S, Tahiri H, Chemtob S. Ischemic retinopathies: oxidative stress and inflammation. Oxid Med Cell Longev. 2017;2017:3940241. doi: 10.1155/2017/3940241. Epub 2017 Dec 19. PMID: 29410732; PMCID: PMC5749295.
Squadrito GL, Pryor WA. Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite, and carbon dioxide. Free Radic Biol Med. 1998; 25(4-5):392-403. doi: 10.1016/s0891-5849(98)00095-1. PMID: 9741578.
Lin WC, Jordan BK, Scottoline B, Ostmo SR, Coyner AS, Singh P, et al. Oxygenation fluctuations associated with severe retinopathy of prematurity: Insights from a multimodal deep learning approach. Ophthalmol Sci. 2023;4(2):100417. doi: 10.1016/j.xops.2023.100417. PMID: 38059124; PMCID: PMC10696464.
Malamas A, Chranioti A, Tsakalidis C, Dimitrakos SA, Mataftsi A. The omega-3 and retinopathy of prematurity relationship. Int J Ophthalmol. 2017;10(2):300-305. doi: 10.18240/ijo.2017.02.19. PMID: 28251092; PMCID: PMC5313556.
Bányász I, Bokodi G, Vannay A, Szebeni B, Treszl A, Vásárhelyi B, et al. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res. 2006;31(7-8):685-90. doi: 10.1080/02713680600801123. PMID: 16877277.
Mohamed S, Schaa K, Cooper ME, Ahrens E, Alvarado A, Colaizy T, et al. Genetic contributions to the development of retinopathy of prematurity. Pediatr Res. 2009 Feb;65(2):193-7. doi: 10.1203/PDR.0b013e31818d1dbd. PMID: 18787502; PMCID: PMC2671288.
Ortega-Molina JM, Anaya-Alaminos R, Uberos-Fernández J, Solans-Pérez de Larraya A, Chaves-Samaniego MJ, Salgado-Miranda A, et al. Genetic and environmental influences on retinopathy of prematurity. Mediators Inflamm. 2015; 2015:764159. doi: 10.1155/2015/764159. Epub 2015 May 21. PMID: 26089603; PMCID: PMC4454750.
Ates O, Alp HH, Caner I, Yildirim A, Tastekin A, Kocer I, Baykal O. Oxidative DNA damage in retinopathy of prematurity. Eur J Ophthalmol. 2009; 19(1):80-5. doi: 10.1177/112067210901900112. PMID: 19123153.
Di Fioreja JM, Vento M. Intermittent hypoxemia and oxidative stress in preterm infants. Respir Physiol Neurobiol. 2019;266:121-129. doi: 10.1016/j.resp.2019.05.006. Epub 2019 May 14. PMID: 31100375; PMCID: PMC6561791.
Ziylan Ş, Öztürk V, Yabaş-Kızıloğlu Ö, Çiftçi F. Myopia, visual acuity and strabismus in the long term following treatment of retinopathy of prematurity. Turk J Pediatr. 2014; 56(5):518-23. PMID: 26022588.
Tsai ASH, Yip M, Song A, Tan GSW, Ting DSW, Campbell JP, et al. Implementation of artificial intelligence in retinopathy of prematurity care: Challenges and opportunities. Int Ophthalmol Clin. 2024;64(4):9-14. doi: 10.1097/IIO.0000000000000532. Epub 2024 Oct 29. PMID: 39480203.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Igor Isjanovski, Stefan Pandilov, Emilija Gjoshevska-Dashtevska

This work is licensed under a Creative Commons Attribution 4.0 International License.
All wrights are reserved.


